129 related articles for article (PubMed ID: 28757416)
21. miR-137 inhibits glutamine catabolism and growth of malignant melanoma by targeting glutaminase.
Luan W; Zhou Z; Zhu Y; Xia Y; Wang J; Xu B
Biochem Biophys Res Commun; 2018 Jan; 495(1):46-52. PubMed ID: 29097210
[TBL] [Abstract][Full Text] [Related]
22. The "melanoma-enriched" microRNA miR-4731-5p acts as a tumour suppressor.
Stark MS; Tom LN; Boyle GM; Bonazzi VF; Soyer HP; Herington AC; Pollock PM; Hayward NK
Oncotarget; 2016 Aug; 7(31):49677-49687. PubMed ID: 27331623
[TBL] [Abstract][Full Text] [Related]
23. The T-box transcription factor, TBX3, is sufficient to promote melanoma formation and invasion.
Peres J; Prince S
Mol Cancer; 2013 Oct; 12(1):117. PubMed ID: 24098938
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors.
Xu Y; Brenn T; Brown ER; Doherty V; Melton DW
Br J Cancer; 2012 Jan; 106(3):553-61. PubMed ID: 22223089
[TBL] [Abstract][Full Text] [Related]
25. MicroRNAs in melanoma biology.
Kunz M
Adv Exp Med Biol; 2013; 774():103-20. PubMed ID: 23377970
[TBL] [Abstract][Full Text] [Related]
26. miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy.
Bhattacharya A; Schmitz U; Raatz Y; Schönherr M; Kottek T; Schauer M; Franz S; Saalbach A; Anderegg U; Wolkenhauer O; Schadendorf D; Simon JC; Magin T; Vera J; Kunz M
Oncotarget; 2015 Feb; 6(5):2966-80. PubMed ID: 25650662
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-137 represses Klf4 and Tbx3 during differentiation of mouse embryonic stem cells.
Jiang K; Ren C; Nair VD
Stem Cell Res; 2013 Nov; 11(3):1299-313. PubMed ID: 24084696
[TBL] [Abstract][Full Text] [Related]
28. Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines.
Essa S; Reichrath S; Mahlknecht U; Montenarh M; Vogt T; Reichrath J
Anticancer Res; 2012 Jan; 32(1):383-9. PubMed ID: 22213330
[TBL] [Abstract][Full Text] [Related]
29. Stathmin 1 is a potential novel oncogene in melanoma.
Chen J; Abi-Daoud M; Wang A; Yang X; Zhang X; Feilotter HE; Tron VA
Oncogene; 2013 Mar; 32(10):1330-7. PubMed ID: 22665054
[TBL] [Abstract][Full Text] [Related]
30. miR-17 regulates melanoma cell motility by inhibiting the translation of ETV1.
Cohen R; Greenberg E; Nemlich Y; Schachter J; Markel G
Oncotarget; 2015 Aug; 6(22):19006-16. PubMed ID: 26158900
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA HEIH promotes melanoma cell proliferation, migration and invasion via inhibition of
Zhao H; Xing G; Wang Y; Luo Z; Liu G; Meng H
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28487474
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.
Satzger I; Mattern A; Kuettler U; Weinspach D; Voelker B; Kapp A; Gutzmer R
Int J Cancer; 2010 Jun; 126(11):2553-62. PubMed ID: 19830692
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration.
Sarver AL; Li L; Subramanian S
Cancer Res; 2010 Dec; 70(23):9570-80. PubMed ID: 21118966
[TBL] [Abstract][Full Text] [Related]
34. miR-211 and MITF modulation by Bcl-2 protein in melanoma cells.
De Luca T; Pelosi A; Trisciuoglio D; D'Aguanno S; Desideri M; Farini V; Di Martile M; Bellei B; Tupone MG; Candiloro A; Regazzo G; Rizzo MG; Del Bufalo D
Mol Carcinog; 2016 Dec; 55(12):2304-2312. PubMed ID: 26599548
[TBL] [Abstract][Full Text] [Related]
35. The T-Box transcription factor 3 in development and cancer.
Willmer T; Cooper A; Peres J; Omar R; Prince S
Biosci Trends; 2017 Jul; 11(3):254-266. PubMed ID: 28579578
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
[TBL] [Abstract][Full Text] [Related]
37. miR-4262 promotes the proliferation of human cutaneous malignant melanoma cells through KLF6-mediated EGFR inactivation and p21 upregulation.
Zhang D; Li Z; Zhang Y; Tu C; Huo J; Liu Y
Oncol Rep; 2016 Dec; 36(6):3657-3663. PubMed ID: 27779691
[TBL] [Abstract][Full Text] [Related]
38. miRNA-7-5p inhibits melanoma cell migration and invasion.
Giles KM; Brown RA; Epis MR; Kalinowski FC; Leedman PJ
Biochem Biophys Res Commun; 2013 Jan; 430(2):706-10. PubMed ID: 23206698
[TBL] [Abstract][Full Text] [Related]
39. Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma.
Abe F; Kitadate A; Ikeda S; Yamashita J; Nakanishi H; Takahashi N; Asaka C; Teshima K; Miyagaki T; Sugaya M; Tagawa H
Oncotarget; 2017 Jan; 8(5):7572-7585. PubMed ID: 27935859
[TBL] [Abstract][Full Text] [Related]
40. miR-337 can be a key negative regulator in melanoma.
Xiao W; Yao E; Zheng W; Tian F; Tian L
Cancer Biol Ther; 2017 Jun; 18(6):392-399. PubMed ID: 28498028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
